Rockbridge Investment Management’s Elevance Health ELV Stock Holding History

Rockbridge Investment Management’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-9	Closed	-$4.25K	–	270
2023 Q4	$4.25K	Buy	+9	New	+$4.16K	﹤0.01%	480
2022 Q3	–	Sell	-9	Closed	-$4.34K	–	255
2022 Q2	$4.34K	Hold	9	–	–	﹤0.01%	477
2022 Q1	$4.49K	Hold	9	–	–	﹤0.01%	639
2021 Q4	$4K	Hold	9	–	–	﹤0.01%	676
2021 Q3	$3K	Hold	9	–	–	﹤0.01%	643
2021 Q2	$3K	Hold	9	–	–	﹤0.01%	640
2021 Q1	$3K	Hold	9	–	–	﹤0.01%	614
2020 Q4	$3K	Hold	9	–	–	﹤0.01%	602
2020 Q3	$2K	Sell	9 -57	-86%	-$15.3K	﹤0.01%	585
2020 Q2	$17K	Buy	+66	New	+$17.6K	﹤0.01%	357

Other funds holding ELV

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Rockbridge Investment Management's ELV Position: Q1 2024 in Review

Rockbridge Investment Management sold out of Elevance Health (ELV) in Q1 2024, closing a stake of 9 shares — an estimated $4.25K sold.

Rockbridge Investment Management first reported a position in ELV in Q2 2020 and held it in 10 quarters. The position peaked at $17K in Q2 2020. 1,666 funds tracked by Wall St. Rank hold ELV as of Q1 2024.

Rockbridge Investment Management reported no remaining Elevance Health position as of Q1 2024 after selling out during the quarter.
Rockbridge Investment Management sold 9 Elevance Health shares in Q1 2024, an estimated $4.25K.
Rockbridge Investment Management first reported a position in Elevance Health in Q2 2020 and held it in 10 quarters.
Rockbridge Investment Management's Elevance Health position peaked at $17K in Q2 2020.
1,666 funds tracked by Wall St. Rank held Elevance Health as of Q1 2024.

Based on Rockbridge Investment Management's 13F filing for Q1 2024, filed 15 May 2024.